MedTrace Logo

Support Groups for Patients With Mild Cognitive Impairment and Their Partners

NCT00285753 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2008-05-21

No results posted yet for this study

Summary

This study aims at developing and evaluating a support group program for patients with mild cognitive impairment (MCI) and their partners. These patients have defective memory function but are not demented. However, there is an increased chance of developing dementia in the near future; 10-15% per year for MCI patients, in contrast to 1-2% per year for healthy elderly persons. For the patients and their caregivers this means that they are confronted with feelings of uncertainty and fear towards the future. They also have many questions about how to improve their memory problems and how to cope with other changes or consequences.

The purpose of the support group program is to improve coping skills and facilitate adaptation to the impairments, in order to reduce anxiety or depression and strengthen feelings of competence in patients and their partners.

Conditions

Interventions

BEHAVIORAL

support groups

cognitive behavioral intervention with psychoeducation

Sponsors & Collaborators

  • Netherlands Alzheimer Foundation

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jan Pieter Teunisse, PhD · Radboud University Medical Center

  • Floor Kraaimaat, Professor · Radboud University Medical Center

  • Marcel Olde Rikkert, Professor · Coordinator Alzheimer Centre UMC Nijmegen

  • Myrra Vernooy, PhD · Coordinator Alzheimer Centre UMC Nijmegen

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00285753 on ClinicalTrials.gov